November 23, 2009

PENWEST PHARMACEUTICALS: Patent Deal with Actavis Pending Review

COMPANIES:
Subscribe

The patent dispute settlement between Penwest Pharmaceuticals Co., Endo Pharmaceuticals Inc., and Actavis is subject to the review of the U.S. Federal Trade Commission and Department of Justice.

On Feb. 14,…

TO CONTINUE READING,LOGIN or
TOPICS: Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: